Condition
Coronary Stent Restenosis
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed1
Recruiting1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04862052Not ApplicableCompletedPrimary
Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis
NCT07316504Not ApplicableRecruiting
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
NCT00244647Phase 1Terminated
A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
NCT00226525Not ApplicableUnknownPrimary
Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation
Showing all 4 trials